We are a biotechnology research corporation striving for the development of health solutions for people, with a special focus on maternal and fetal health, human reproduction, and women’s health.
MELISA integrates diverse areas of human life sciences including basic sciences, epidemiology, and clinical medicine. Our institution’s core capabilities include: advanced research in proteogenomics and the development and manufacturing of medical products with diagnostic or therapeutic applications. In addition, MELISA Institute is interested in investigating social, economical, and biological determinants of health at the population level.
During the current global health emergency provoked by the COVID-19 outbreak, MELISA Institute rapidly adapted its research platform to collaborate in investigating clinical applications and possible solutions to this major public health crisis.
A randomized Clinical Trial to prevent Covid-19
MELISA Institute’s research aims for chemoprophylaxis against Covid-19 through the use of Previfenon®, preventing an effective incubation and enhancing systemic immunity.